Abstract C180: Not all PIRADS 3s are equal; fusion biopsy outcomes by PIRADS score and ethnicity in a diverse population

Abstract Introduction and Objective: Magnetic resonance imaging (MRI) is increasingly utilized in the diagnosis of prostate cancer (PCa). Although PIRADS 3 lesions have been associated with a lower likelihood of detecting clinically significant prostate cancer (csPCa) at the time of targeted fusion biopsy (FB), existing data on multiethnic populations are sparse. We assessed the pathologic concordance of PIRADS 3 vs 4 or 5 lesions in detection of PCa and csPCa in comparison to PSA density in a diverse population. Methods: A retrospective study of all patients who underwent image-guided FB for PIRADS 3-5 lesions from 2016-2022 was conducted. Demographic, clinical, and pathologic data were extracted from electronic medical records. Mixed-effects logistic regression models were used to examine the association of race/ethnicity and PSA density with risks of overall PCa and csPCa. A stratified analysis by PIRADS score (3 vs 4 or 5) was also carried out to explore the associations between detection rates of PCa and race/ethnicity. Results: A total of 565 men with 997 lesions were analyzed, with average age 63.2 years (SD: 7.5) at the time of biopsy. Of the men, 279 (49.4%) were Non-Hispanic Black (NHB), 112 (19.8%) were Non-Hispanic White, and 174 (30.8%) were Hispanic. 520 (52.16%), 310 (31.09%), and 167 (16.75%) individual MRI lesions were PIRADS 3, 4, and 5, respectively with distributions of PIRADS scores being similar across all race/ethnicities. The overall rates of PCa detection were 44.8% in NHB, 37.6% in Hispanics, and 33.0% in NHW. Compared to NHW, NHB has 2.52 higher odds of detecting overall PCa (95% CI 1.10-5.78; p = 0.03), whereas Hispanic men had an OR = 1.18 (p = 0.72). Interestingly, the increase in PCa detection among NHB was only observed for PIRADs 3 lesions (OR = 4.84 95% CI 1.11-21.2, p = 0.04). NHB men also had 2.1-fold higher odds of detecting csPCa (95% CI 0.92-4.77; p = 0.08) in comparison to NHW with a similar trend mimicking association with PRIADS scores, although results were not statistically significant. Conclusions: We report that NHB men have higher odds of detection rates of overall PCa in FB in comparison to NHW and Hispanic men, albeit only at PIRADS 3 scores. These findings may serve to improve risk stratification and assist with shared decision making when discussing triggers for biopsy. Source of funding: None Citation Format: David G. Hanelin, Andrewe Baca, Priya Dave, Rutul Patel, Ilir Agalliu, Alexander Sankin, Ahmed Aboumohamed, Kara Watts. Not all PIRADS 3s are equal; fusion biopsy outcomes by PIRADS score and ethnicity in a diverse population [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr C180.

Authors

Institutions

Publication Details

Journal
Cancer Epidemiology Biomarkers & Prevention
Published
2024-09-21
DOI
https://doi.org/10.1158/1538-7755.disp24-c180
Primary Topic
Medical Imaging and Pathology Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract C180: Not all PIRADS 3s are equal; fusion biopsy outcomes by PIRADS score and ethnicity in a diverse population

Alexander Sankin, Rutul D. Patel, Ahmed Aboumohamed, Priya Dave et al.
Cancer Epidemiology Biomarkers & Prevention
Medical Imaging and Pathology Studies
article

Abstract C180: Not all PIRADS 3s are equal; fusion biopsy outcomes by PIRADS score and ethnicity in a diverse population

Alexander Sankin, Rutul D. Patel, Ahmed Aboumohamed, Priya Dave, Ilir Agalliu, David Hanelin, Kara Watts, Andrewe Baca
article en

Abstract

Abstract Introduction and Objective: Magnetic resonance imaging (MRI) is increasingly utilized in the diagnosis of prostate cancer (PCa). Although PIRADS 3 lesions have been associated with a lower likelihood of detecting clinically significant prostate cancer (csPCa) at the time of targeted fusion biopsy (FB), existing data on multiethnic populations are sparse. We assessed the pathologic concordance of PIRADS 3 vs 4 or 5 lesions in detection of PCa and csPCa in comparison to PSA density in a diverse population. Methods: A retrospective study of all patients who underwent image-guided FB for PIRADS 3-5 lesions from 2016-2022 was conducted. Demographic, clinical, and pathologic data were extracted from electronic medical records. Mixed-effects logistic regression models were used to examine the association of race/ethnicity and PSA density with risks of overall PCa and csPCa. A stratified analysis by PIRADS score (3 vs 4 or 5) was also carried out to explore the associations between detection rates of PCa and race/ethnicity. Results: A total of 565 men with 997 lesions were analyzed, with average age 63.2 years (SD: 7.5) at the time of biopsy. Of the men, 279 (49.4%) were Non-Hispanic Black (NHB), 112 (19.8%) were Non-Hispanic White, and 174 (30.8%) were Hispanic. 520 (52.16%), 310 (31.09%), and 167 (16.75%) individual MRI lesions were PIRADS 3, 4, and 5, respectively with distributions of PIRADS scores being similar across all race/ethnicities. The overall rates of PCa detection were 44.8% in NHB, 37.6% in Hispanics, and 33.0% in NHW. Compared to NHW, NHB has 2.52 higher odds of detecting overall PCa (95% CI 1.10-5.78; p = 0.03), whereas Hispanic men had an OR = 1.18 (p = 0.72). Interestingly, the increase in PCa detection among NHB was only observed for PIRADs 3 lesions (OR = 4.84 95% CI 1.11-21.2, p = 0.04). NHB men also had 2.1-fold higher odds of detecting csPCa (95% CI 0.92-4.77; p = 0.08) in comparison to NHW with a similar trend mimicking association with PRIADS scores, although results were not statistically significant. Conclusions: We report that NHB men have higher odds of detection rates of overall PCa in FB in comparison to NHW and Hispanic men, albeit only at PIRADS 3 scores. These findings may serve to improve risk stratification and assist with shared decision making when discussing triggers for biopsy. Source of funding: None Citation Format: David G. Hanelin, Andrewe Baca, Priya Dave, Rutul Patel, Ilir Agalliu, Alexander Sankin, Ahmed Aboumohamed, Kara Watts. Not all PIRADS 3s are equal; fusion biopsy outcomes by PIRADS score and ethnicity in a diverse population [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr C180.

Cancer Epidemiology Biomarkers & PreventionVol. 33(9_Supplement)
Albert Einstein College of Medicine (US), Montefiore Medical Center (US)
Openalex Percentile: Top 71%
Medical Imaging and Pathology Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.